Though March saw the return to daylight saving time and the NCAA Division I Men’s Basketball Tournament, the new product team at Hamacher Resource Group still found time to assess 445 new products and select five standouts.
New data from the Consumer Healthcare Products Association and IRI is highlighting the ripple effect that a consumer buying an OTC product can have on the American healthcare system — namely, some $146 billion in savings.
GlaxoSmithKline will have a controlling 68% equity interest and Pfizer will have a 32% equity interest in the joint venture, which would have a global OTC market share of 7.3%, leading the market in most key geographical areas, including the United States and China.
Dr. Reddy’s Laboratories has received the Food and Drug Administration’s nod for an over-the-counter generic version of AstraZeneca’s Nexium 24 hour capsules (esomeprazole magnesium delayed-release capsules) in a 20-mg dosage strength.
FDA's decision impacts five manufacturers with PEG 3350 ANDA approvals, including Kremers Urban Pharmaceuticals, Breckenridge Pharmaceutical, Nexgen Pharma, Paddock Laboratories and Teva Pharmaceutical.